Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News and Analysis
  • Published:

Mixed results for disease-modification strategies for Alzheimer's disease

Nature Reviews Drug Discovery volume 7, pages 717–718 (2008)Cite this article

High-profile programmes aiming to develop the first disease-modifying drug for Alzheimer's disease have suffered major setbacks recently, but there is still strong support for a range of efforts to transform disease treatment.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Alisa Opar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Opar, A. Mixed results for disease-modification strategies for Alzheimer's disease. Nat Rev Drug Discov 7, 717–718 (2008). https://doi.org/10.1038/nrd2676

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd2676

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing